How many institutions held CDMO - Avid Bioservices, Inc. - Common Stock, par value $0.001 per share in Q3 2025?

1 institutional investor reported CDMO - Avid Bioservices, Inc. - Common Stock, par value $0.001 per share for Q3 2025. Use the holders table for investor-level position and value details.

Avid Bioservices, Inc. - Common Stock, par value $0.001 per share (CDMO)

Q: What does CUSIP 05368M106 represent in this 13F holders report?

CUSIP 05368M106 is the security identifier for CDMO - Avid Bioservices, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 05368M106

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 64,369,712
Total 13F shares: 134,598
Share change: +134,598
Total reported value: $1,531,725
Price per share: $11.38
Number of holders: 1
Value change: +$1,531,725
Number of buys: 1

Quarterly Holders Quick Answers

What is CUSIP 05368M106?
CUSIP 05368M106 identifies CDMO - Avid Bioservices, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2025
Previous quarter: Q2 2025

Recent filing periods for CUSIP 05368M106:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of CDMO - Avid Bioservices, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
AltraVue Capital, LLC	13D/G	—	5.9%	3,797,813	$47,190,485	$0	31 Dec 2024	13D/G
Nicholas S. Green	3/4/5	President & CEO, Director	— mixed-class rows	1,857,311 mixed-class rows	$22,736,758	—	05 Feb 2025	3/4/5
Daniel R. Hart	3/4/5	Chief Financial Officer	— mixed-class rows	464,325 mixed-class rows	$5,674,052	—	05 Feb 2025	3/4/5
Matthew R. Kwietniak	3/4/5	Chief Commercial Officer	— mixed-class rows	312,457 mixed-class rows	$3,818,224	—	05 Feb 2025	3/4/5
Richard A. Richieri	3/4/5	Chief Operations Officer	— mixed-class rows	225,578 mixed-class rows	$2,756,563	—	05 Feb 2025	3/4/5

Institutional Holders of Avid Bioservices, Inc. - Common Stock, par value $0.001 per share (CDMO) as of Q3 2025

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders

Q3 2025 holders

Holder diff

Investor	Q2 2025 Shares	Q3 2025 Shares	Share Diff	Share Chg %	Q2 2025 Value $	Q3 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.